Clearmind Medicine Inc. Weighted Average Fair Value At Measurement Date Share Options Granted
Clearmind Medicine Inc. (CMND) had Weighted Average Fair Value At Measurement Date Share Options Granted of CAD 12.75 as of 2022-10-31, per its 20-F filed 2023-02-06.
Discontinued › Notes
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted · last filed 2023-02-06
- 2022-10-31: Weighted Average Fair Value At Measurement Date Share Options Granted 12.75 CAD.
- 2021-10-31: Weighted Average Fair Value At Measurement Date Share Options Granted 13.80 CAD.
| Period end | Weighted Average Fair Value At Measurement Date Share Options Granted |
|---|---|
| 2022-10-31 | 12.75 CAD 20-F · filed 2023-02-06 |
| 2021-10-31 | 13.80 CAD 20-F · filed 2023-02-06 |